# A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

> **NCT00812799** · PHASE3 · UNKNOWN · sponsor: **Artu Biologicals** · enrollment: 374 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** Oralgen
- **OTHER:** placebo control

## Key facts

- **NCT ID:** NCT00812799
- **Lead sponsor:** Artu Biologicals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2010-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812799, "A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00812799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*